Exendin-4 is a peptide that shares 53% sequence homology with human GLP-1 and can bind and activate GLP-1 receptors with similar potency to GLP-1RAs
MMI mice received 5 daily T3 injection at a dose of 0.25 g per gram BW were euthanized 24 h after last T3 injection (MMI + T3-5d mice)
Bednarek AK, Chu Y, Aldaz CM
DSIP was chemically synthesized using a solid-phase method, with its purity (98.5%) confirmed by HPLC, NMR, and MS data
Novo Nordisk previously claimed to have been alarmed by "reports of medical spas, weight loss clinics, pharmacies, and other companies" selling compounded semaglutide to patients on the grounds that they "do not have the same safety, quality, and effectiveness assurances as Novo Nordisk's FDA-approved drugs." Compounding pharmacies are mostly regulated at the state level by boards of pharmacy